Diagnosis and treatment of autism spectrum disorders

Current Problems in Pediatric and Adolescent Health Care

Volumn 33, Issue 9, 2003, Pages 283-304

  Manning Courtney, Patricia ^a,b   Brown, Jennifer ^a   Molloy, Cynthia A ^a,b   Reinhold, Judy ^a   Murray, Donna ^a,b,c   Sorensen Burnworth, Rena ^a,b   Messerschmidt, Teri ^a   Kent, Bridget ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHELATING AGENT; CLONIDINE; DIMETHYLGLYCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DRUG PRESERVATIVE; FLUOXETINE; GUANFACINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; MELATONIN; MERCURY; PLACEBO; RISPERIDONE; SECRETIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; THIOMERSAL; VALPROATE SEMISODIUM;

AUTISM; CHELATION THERAPY; CHILD; CHILD BEHAVIOR; CHILD NUTRITION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG FORMULATION; DRUG HYPERSENSITIVITY; EDUCATION PROGRAM; FAMILY COUNSELING; FEMALE; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; LIVER TOXICITY; MALE; MERCURIALISM; OCCUPATIONAL THERAPY; PRIMARY MEDICAL CARE; REVIEW; SCHOOL; SCREENING TEST; SOMNOLENCE; SPEECH THERAPY; TREATMENT INDICATION;

EID: 0242636502     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-5442(03)00108-1     Document Type: Article

References (196)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
2. Meloni I, Bruttini M, Longo I, et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000;67:982-5.
3. Ritvo E, Freeman B, Ornitz E, et al. Autism: Diagnosis, Current Research and Management. New York: Spectrum Publications, Inc; 1976.
4. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-250.
5. Wing L. The Autistic Spectrum: A Guide for Parents and Professionals. London: Constable; 1996.
6. Bettelheim B. The Empty Fortress. New York: The Free Press; 1967.
7. Schain R, Yannet H. Infantile autism. J Pediatr 1960;57: 560-7.
8. Deykin E, MacMahon B. The incidence of seizures among children with autistic syndromes. Am J Psychiatry 1979;136: 1310-2.
9. DeMyer M, Pontius W, Norton J, et al. Parental practices and innate activity in normal autistic and brain-damaged infants. J Autism Childhood Schizophrenia 1972;2:49-66.
10. Cantwell D, Baker L, Rutter M. Families of autistic and dysphasic children. Arch Gen Psychiatry 1979;36:682-7.
11. Hashimoto T, Murakawa K, Miyazaki M, et al. Magnetic resonance imaging of the brain structures in the posterior fossa in retarded autistic children. Acta Paediatr 1992;81: 1030-4.
12. Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol 1997; 7:269-78.
13. Maestrini E, Marlow AJ, Weeks DE, et al. Molecular genetic investigations of autism. J Autism Dev Disord 1998;28:427-37.
14. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001;2:943-55.
15. Bryson SE. Brief report: epidemiology of autism. J Autism Dev Disord 1996;26:165-7.
16. Mesibov G, Adams L, Klinger L. Autism: Understanding the Disorder. New York: Plenum; 1997.
17. Scott F, Baron-Cohen S, Bolton P, et al. Brief report: prevalence of autism spectrum conditions in children aged 5-11 years in Cambridgeshire, UK. Autism 2002;6:231-7.
18. Baker HC. A comparison study of autism spectrum disorder referrals 1997 and 1989. J Autism Dev Disord 2002;32: 121-5.
19. Janzen J. Autism: Facts and Strategies for Parents. San Antonio: Therapy Skill Builders; 1999.
20. Bryson SE, Clark BS, Smith IM. First report of a Canadian epidemiological study of autistic syndromes. J Child Psychol Psychiatry 1988;29:433-45.
21. Ritvo ER, Mason-Brothers A, Freeman BJ, et al. The UCLA-University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry 1990; 147:1614-21.
22. Gillberg C, Steffenburg S, Schaumann H. Is autism more common now than ten years ago? Br J Psychiatry 1991;158: 403-9.
23. Yeargin-Allsopp M, Rice C, Karapurkar T, et al. Prevalence of Autism in Metropolitan Atlanta in 1996. Presented at the International Meeting for Autism Research 2001; San Diego, Calif.
24. Bertrand J, Mars A, Boyle C, et al. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001;108:1155-61.
25. Fiona JS, Baron-Cohen S, Bolton P, et al. Brief report: prevalence of autism spectrum conditions in children aged 5-11 years in Cambridgeshire, UK. Autism 2002;6:231-7.
26. Byrd R. Report to the legislature of the principal findings from the epidemiology of autism in California: a comprehensive pilot study. Davis: University of California; 2002.
27. Croen LA, Grether JK, Hoogstrate J, et al. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-15.
28. Fombonne E. The epidemiology of autism: a review. Psychol Med 1999;29:769-86.
29. Barton M, Volkmar F. How commonly are known medical conditions associated with autism? J Autism Dev Disord 1998;28:273-8.
30. Gillberg C, Coleman M. The biology of the autistic syndromes. 3rd edition. London: MacKieth Press; 2000.
31. Rogers SJ. Brief report: early intervention in autism. J Autism Dev Disord 1996;26:243-6.
32. Charman T, Baird G. Practitioner review: diagnosis of autism spectrum disorder in 2- and 3-year-old children. J Child Psychol Psychiatry 2002;43:289-305.
33. Szatmari P, Jones MB, Zwaigenbaum L, et al. Genetics of autism: overview and new directions. J Autism Dev Disord 1998;28:351-68.
34. Screening infants and young children for developmental disabilities: American Academy of Pediatrics Committee on Children with Disabilities. Pediatrics 1994;93:863-5.
35. Howlin P, Asgharian A. The diagnosis of autism and Asperger syndrome: findings from a survey of 770 families. Dev Med Child Neurol 1999;41:834-9.
36. Filipek PA, Accardo, PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;29:439-84.
37. Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children.Pediatrics 2001;107:E85.
38. American Academy of Pediatrics. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001;107:1221-6.
39. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 1997;99:560-6.
40. Adrien JL, Lenoir P, Martineau J, et al. Blind ratings of early symptoms of autism based upon family home movies. J Am Acad Child Adolesc Psychiatry 1993;32:617-26.
41. Osterling J, Dawson G. Early recognition of children with autism: a study of first birthday home videotapes. J Autism Dev Disord 1994;24:247-57.
42. Baron-Cohen S, Wheelwright S, Cox A, et al. Early identification of autism by the CHecklist for Autism in Toddlers (CHAT). J R Soc Med 2000;93:521-5.
43. Robins DL, Fein D, Barton ML, et al. The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord 2001;31:131-44.
44. Siegel B. The Pervasive Developmental Disorder Screening Test-Stage. San Francisco: University of California; 2001.
45. Piven J, Wzorek M, Landa R, et al. Personality characteristics of the parents of autistic individuals. Psychol Med 1994;24:783-95.
46. Piven J, Palmer P, Jacobi D, et al. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry 1997;154:185-90.
47. Piven J, Palmer P, Landa R, et al. Personality and language characteristics in parents from multiple-incidence autism families. Am J Med Genet 1997;74:398-411.
48. Lainhart JE, Piven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997;36:282-90.
49. Woodhouse W, Bailey A, Rutter M, et al. Head circumference in autism and other pervasive developmental disorders. J Child Psychol Psychiatry 1996;37:665-71.
50. Davidovitch M, Patterson B, Gartside P. Head circumference measurements in children with autism. J Child Neurol 1996;11:389-93.
51. Shinnar S, Rapin I, Arnold S, et al. Language regression in childhood. Pediatr Neurol 2001;24:183-9.
52. Ballaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: association with autism and language disorders. Ment Retard Dev Disabil Res Rev 2000;6:300-8.
53. Gilliam J. Gilliam Autism Rating Scale. Austin, Tex: Pro-ed; 1995.
54. Stone WL, Hogan KL. A structured parent interview for identifying young children with autism. J Autism Dev Disord 1993;23:639-52.
55. Lord C, Pickles A, McLennan J, et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 1997;27:501-17.
56. Mesibov GB, Schopler E, Schaffer B, et al. Use of the childhood autism rating scale with autistic adolescents and adults. J Am Acad Child Adolesc Psychiatry 1989;28:538-41.
57. Stone WL, Coonrod EE, Ousley OY. Brief report: screening tool for autism in two-year-olds (STAT): development and preliminary data. J Autism Dev Disord 2000;30:607-12.
58. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205-23.
59. Molloy C, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autism spectrum disorders. Autism 2003;7:165-71.
60. Minshew NJ, Sweeney JA, Bauman ML. Neurological aspects of autism. In: Cohen DJ, Volkmar FR, editors. Handbook of Autism and Pervasive Developmental Disorders. New York: John Wiley and Sons, Inc; 1997.
61. DeLong GR, Ritch CR, Burch S. Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement. Dev Med Child Neurol 2002;44:652-9.
62. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314-21.
63. Quintana H, Birmaher B, Stedge D, et al. Use of methylphenidate in the treatment of children with autistic disorder. J Autism Dev Disord 1995;25:283-94.
64. Fankhauser MP, Karumanchi VC, German ML, et al. A double-blind placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992;53: 77-82.
65. Tuchman R. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders. J Autism Dev Disord 2000;30:491-5.
66. Di Martino A, Tuchman RF. Antiepileptic drugs: affective use in autism spectrum disorders. Pediatr Neurol 2001;25: 199-207.
67. Buchsbaum MS, Hollander E, Haznedar MM, et al. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. Int J Neuropsychopharmacol 2001;4:119-25.
68. Kulman G, Lissoni P, Rovelli F, et al. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000;21:31-4.
69. Ishizaki A, Sugama M, Takeuchi N. Usefulness of melatonin for developmental sleep and emotional/behavior disorders: studies of melatonin tril on 50 patients with developmental disorders. No To Hattatsu 1999;31:428-37.
70. Rufo CM. Melatonin and epilepsy. Rev Neurol 2002;35: S51-8.
71. Pfeiffer SI, Norton J, Nelson L, et al. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995;25:481-93.
72. Findling RL, Maxwell K, Scotese-Wojtila J, et al. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 1997; 27:467-78.
73. Bolman WM, Richmond JA. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord 1999; 29:191-4.
74. Kern JK, Miller VS, Cauller PL, et al. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol 2001;16:169-73.
75. Reichelt KL, Kruvsberg A, Lind G, et al. Probable etiology and possible treatment of childhood autism. Brain Dysfunct 1991;4:308-19.
76. Plioplys AV. Intravenous immunoglobulin treatment of children with autism. J Child Neurol 1998;13:79-82.
77. Plioplys AV. Intravenous immunoglobulin treatment in autism. J Autism Dev Disord 2000;30:73-4.
78. DelGiudice-Asch G, Simon L, Schmeidler J, et al. Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism. J Autism Dev Disord 1999;29:157-60.
79. Horvath K, Stephanatos G, Sokolski KN, et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998;9:9-15.
80. Molloy CA, Manning-Courtney P, Swayne S, et al. Lack of benefit of intravenous synthetic human secretin in the treatment of autism. J Autism Dev Disord 2002;32:545-51.
81. Owley T, McMahon W, Cook EH, et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry 2001;40:1293-9.
82. Sandler AD, Sutton KA, DeWeese J, et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 1999;341:1801-6.
83. Dunn-Geier J, Ho HH, Auersperg E, et al. Effect of secretin on children with autism: a randomized controlled trial. Dev Med Child Neurol 2000;42:796-802.
84. Lightdale JR, Hayer C, Duer A, et al. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Pediatrics 2001;108:E90.
85. Roberts W, Weaver L, Brian J, et al. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics 2001;107:E71.
86. Coniglio SJ, Lewis JD, Lang C, et al. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr 2001;138:649-55.
87. Carey T, Ratliff-Schaub K, Funk J, et al. Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. J Autism Dev Disord 2002; 32:161-7.
88. Corbett B, Khan K, Czapansky-Beilman D, et al. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Clin Pediatr (Phila) 2001;40:327-31.
89. Nickel RE. Controversial therapies for young children with developmental disabilities. Infants Young Child 1996;8:29-40.
90. Lord C, Bristol-Power M, Cafiero J, et al. Educating Children with Autism. Washington, DC: National Academy Press; 2001.
91. Gerlach EK. Autism Treatment Guide. 2nd edition. Arlington, Tex: Future Horizons Inc; 2000.
92. Olley J, Reeve C. Issues of curriculum and classroom structure. In: Cohen D, Volkmar F, editors. Handbook of Autism and Pervasive Developmental Disorders. New York: John Wiley & Sons; 1997. p. 484-508.
93. Marcus L, Schopler E, Lord C. TEACCH Services for preschool children. In: Handleman J, Harris S, editors. Preschool education programs for children with autism. Austin, Tex: Pro-Ed; 2000.
94. Panerai S, Ferrante L, Zingale M. Benefits of the Treatment and Education of Autistic and Communication Handicapped Children (TEACCH) programme as compared with a non-specific approach. J Intellect Disabil Res 2002;46:318-27.
95. Lovaas O. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Con Clin Psych 1987;55:3-9.
96. Maurice C. Let Me Hear Your Voice. New York: Fawcett Columbine; 1993.
97. Cooper JO, Heron TE, Heward WL. Applied Behavior Analysis. Upper Saddle River, NJ: Prentice-Hall, Inc; 1987.
98. Anderson SR, Romanczyk RG. Early intervention for young children with autism: continuum-based behavioral models. J Assoc Persons Severe Handicap 1999;24:162-73.
99. Program, N.Y.S.D.o.H.E.I. Clinical practice guideline: report of the recommendations. Autism/PDD assessment and intervention for young children (ages 0-3). Albany, NY: New York State Department of Health; 1999.
100. Jacobson JW, Mulick JA. System and cost research issues in treatments for people with autistic disorders. J Autism Dev Disord 2000;30:585-93.
101. Greenspan S, Wieder S. A developmental approach to difficulties in relating and communicating. In: Weatherby A, Prizant B, editors. Autism spectrum disorders and related syndromes. Baltimore, Md: Paul H. Brookes; 2000. p. 279-303.
102. Harrower JK. Educational inclusion of children with severe disabilities. J Positive Behavior Intervent 1999;1:215-30.
103. Harrower JK, Dunlap G. Including children with autism in general education classrooms: a review of effective strategies. Behav Modif 2001;25:762-84.
104. Fryxell DK, Kennedy CH. Placement along the continuum of services and its impact on students' social relationships. J Assoc Persons Severe Handicap 1995;20:259-69.
105. Dawson G, Osterling J. Early intervention in autism. In: Guralnick MJ, editor. The Effectiveness of Early Intervention. Baltimore, Md: Paul H. Brookes; 1997. p. 307-26.
106. Simpson R, Myles B, editors. Educating Children and Youth with Autism. Austin, Tex: Pro-ed; 1998. p. 343.
107. Baron-Cohen S. Social and pragmatic deficits in autism: cognitive or affective? J Autism Dev Disord 1988;18:379-402.
108. Quill K. Teaching Children with Autism: Strategies to Enhance Communication. Albany: Delmar Publishers, Inc; 1995.
109. Scheuermann B, Webber J. Autism: Teaching Does Make a Difference. Australia: Carlisle Publishers Services; 2002.
110. Baranek GT, Foster LG, Berkson G. Tactile defensiveness and stereotyped behaviors. Am J Occup Ther 1997;51:91-5.
111. Waltz M. Pervasive Developmental Disorders: Finding a Diagnosis and Getting Help. Beijing: O'Reilly & Associates, Inc; 1999.
112. Kientz MA, Dunn W. A comparison of the performance of children with and without autism on the Sensory Profile. Am J Occup Ther 1997;51:530-7.
113. Windeck S, Laurel M. A theoretical framework combining speech-language therapy with sensory integration treatment. Sensory Integration 1989;12:1-5.
114. Catalano R. When Autism Strikes: Families Cope with Childhood Disintegrative Disorder. New York: Plenum Press; 1998.
115. Randall P, Parker J. Supporting the Families of Children with Autism. New York: John Wiley and Sons, Ltd; 1999.
116. Wolff S, Narayan S, Moyes B. Personality characteristics of parents of autistic children. Child Psychol Psychiatry 1988; 29:143-53.
117. Delong GR, Dwyer JT. Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. J Autism Dev Disord 1988;18:593-600.
118. Piven J, Gayle J, Chase GA, et al. A family history study of neuropsychiatric disorders in adult sibling of autistic individuals. J Am Acad Child Adoles Psychiatry 1990;29:177-83.
119. Piven J, Chase GA, Landa R, et al. Psychiatric disorders in the parents of autistic individuals. J Am Acad Child Adoles Psychiatry 1991;30:471-8.
120. Morgan SB. The autistic child and family functioning: a developmental-family systems perspective. J Autism Dev Disord 1988;18:263-80.
121. Howlin P, Moore A. Diagnosis in autism: a survey of over 1200 patients in the UK. Autism Int J Res Pract 1997;1:135-62.
122. Smith B, Chung M, Vostanis P. The path to care in autism: is it better now? J Autism Dev Disord 1994;24:551-63.
123. Wolf L, Noh S, Fisman S, et al. Brief report: psychological effects of parenting stress on parents of autistic children. J Autism Dev Disord 1989;19:157-66.
124. Bristol MM, Cohen DJ, Costello EJ, et al. State of the science in autism: report to the National Institutes Health. J Autism Dev Disord 1996;26:121-54.
125. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977;18:297-321.
126. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
127. Steffenburg S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 1989;30:405-16.
128. Rutter M. Genetic studies of autism: from the 1970s into the millennium. J Abnorm Child Psychol 2000;28:3-14.
129. Pickles A, Bolton P, Macdonald H, et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 1995;57:717-26.
130. Jones MB, Szatmari P. A risk-factor model of epistatic interaction, focusing on autism. Am J Med Genet 2002;114: 558-65.
131. London EA. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 2000;108(Suppl 3):401-4.
132. Risch N, Spiker D, Lotspeich L, et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999;65:493-507.
133. Pierce K, Muller RA, Ambrose J, et al. Face processing occurs outside the fusiform 'face area' in autism: evidence from functional MRI. Brain 2001;124:2059-73.
134. Collaborative Linkage Study of Autism (CLSA). An autosomal genomic screen for autism. Am J Med Genet 2001;105: 609-15.
135. International Molecular Genetic Study of Autism (IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001;69:570-81.
136. Buxbaum JD, Silverman JM, Smith CJ, et al. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 2001;68:1514-20.
137. Liu J, Nyholt DR, Magnussen P, et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001;69:327-40.
138. Shao Y, Wolpert CM, Raiford KL, et al. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 2002;114:99-105.
139. Folstein SE, Mankoski RE. Chromosome 7q: where autism meets language disorder? Am J Hum Genet 2000;67:278-81.
140. Wassink TH, Piven J, Vieland VJ, et al. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 2001;105:406-13.
141. Persico AM, et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 2001;6:150-9.
142. Nurmi EL, Bradford Y, Chen Y, et al. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 2001;77:105-13.
143. Herzing LB, Kim SJ, Cook EH, et al. The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression. Am J Hum Genet 2001;68:1501-5.
144. Menold MM, Shao Y, Wolpert CM, et al. Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder. J Neurogenet 2001;15:245-59.
145. Nan X, Bird A. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain Dev 2001;23(Suppl 1):S32-7.
146. Orrico A, Lam C, Galli L, et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 2000;481:285-8.
147. Hammer S, Dorrani N, Dragichi J, et al. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:94-8.
148. Beyer KS, Blasi F, Bacchelli E, et al. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002;111:305-9.
149. Lord C, Leventhal BL, Cook EH Jr. Quantifying the phenotype in autism spectrum disorders. Am J Med Genet 2001; 105:36-8.
150. Alarcon M, Cantor RM, Liu J, et al. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002;70:60-71.
151. Stromland K, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351-6.
152. Williams G, King J, Cunningham M, et al. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001;43:202-6.
153. Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr 1977;7:69-81.
154. Ivarsson SA, Bjerre I, Vegfors P, et al. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990;21:102-3.
155. Stubbs EG, Ash E, Williams CP. Autism and congenital cytomegalovirus. J Autism Dev Disord 1984;14:183-9.
156. Patterson PH. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002;12:115-8.
157. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001; 120:170-9.
158. Gupta S, Aggarwal S, Rashanravan B, et al. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998;85:106-9.
159. Croonenberghs J, Bosmans E, Deboutte D, et al. Activation of the inflammatory response system in autism. Neuropsychobiology 2002;45:1-6.
160. Singh VK. Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism. J Neuroimmunol 1996;66:143-5.
161. Comi AM, Zimmerman AW, Frye VH, et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999;14:388-94.
162. Szatmari P. Heterogeneity and the genetics of autism. J Psychiatry Neurosci 1999;24:159-65.
163. Miles JH, Hillman RE. Value of a clinical morphology examination in autism. Am J Med Genet 2000;91:245-53.
164. Briskman J, Happe F, Frith U. Exploring the cognitive phenotype of autism: weak "central coherence" in parents and siblings of children with autism, II: real-life skills and preferences. J Child Psychol Psychiatry 2001;42:309-16.
165. Bradford Y, Haines J, Hutcheson H, et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001;105:539-47.
166. Melmed R, Schneider C, Fabes R, et al. Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. J Pediatr Gastroenterol Nutr 2000;31: S31-2.
167. D'Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996;85:1076-9.
168. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
169. Wakefield AJ. Enterocolitis, autism and measles virus. Mol Psychiatry 2002;7(Suppl 2):S44-6.
170. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-82.
171. Peltola H, Patja A, Leinikki P, et al. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998;351:1327-8.
172. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
173. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001; 108:E58.
174. Bernard S, Enayati A, Roger H, et al. The role of mercury in the pathogenesis of autism. Mol Psychiatry 2002;7(Suppl 2):S42-3.
175. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001;107:1147-54.
176. Starkstein SE, Vazquez S, Vrancic D, et al. SPECT findings in mentally retarded autistic individuals. J Neuropsychiatry Clin Neurosci 2000;12:370-5.
177. Sears LL, Vest C, Mohamed S, et al. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:613-24.
178. Saitoh O, Karns CM, Courchesne E. Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain 2001;124:1317-24.
179. Haznedar PF, Buchsbaum MS, Wei TC, et al. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry 2000;157:1994-2001.
180. Bolton PF, Griffiths PD. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 1997;349:392-5.
181. Schultz RT, Gauthier I, Klin A, et al. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 2000;57:331-40.
182. Egaas B, Courchesne E, Saitoh O. Reduced size of corpus callosum in autism. Arch Neurol 1995;52:794-801.
183. Hardan AY, et al. Posterior fossa magnetic resonance imaging in autism. J Am Acad Child Adolesc Psychiatry 2001; 40:666-72.
184. Bauman ML. Brief report: neuroanatomic observations of the brain in pervasive developmental disorders. J Autism Dev Disord 1996;26:199-203.
185. Bobee S, Mariette E, Tremblay-Leveau H, et al. Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat. Behav Brain Res 2000;112:107-17.
186. Courchesne E, Saitoh O, Townsend JP, et al. Cerebellar hypoplasia and hyperplasia in infantile autism. Lancet 1994; 343:63-4.
187. Courchesne E. New evidence of cerebellar and brainstem hypoplasia in autistic infants, children and adolescents: the MR imaging study by Hashimoto and colleagues. J Autism Dev Disord 1995;25:19-22.
188. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998;57:645-52.
189. Shavelle RM, Strauss DJ, Pickett J. Causes of death in autism. J Autism Dev Disord 2001;31:569-76.
190. Pickett J. Current investigations in autism brain tissue research. J Autism Dev Disord 2001;31:521-7.
191. Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001;57:245-54.
192. Insel TR. Mouse models for autism: report from a meeting. Mamm Genome 2001;12:755-7.
193. Mullen RJ, Hamre KM, Goldowitz D. Cerebellar mutant mice and chimeras revisited. Perspect Dev Neurobiol 1997; 5:43-55.
194. Brown JR, Ye H, Bronson RT, et al. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 1996;86: 297-309.
195. Fatemi SH. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 2001;6:129-33.
196. Winslow JT, Insel TR. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002;36:221-9.